Centrizonal arteries and microvessels in nonalcoholic steatohepatitis

American Journal of Surgical Pathology

Volumn 35, Issue 9, 2011, Pages 1400-1404

  Gill, Ryan M ^a   Belt, Patricia ^a   Wilson, Laura ^a   Bass, Nathan M ^b   Ferrell, Linda D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

angiogenesis; central zones; hepatic vasculature; nonalcoholic fatty liver disease; steatohepatitis

Indexed keywords

CD34 ANTIGEN;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTERIOLE; ARTICLE; BIOPSY; CHI SQUARE DISTRIBUTION; DISEASE COURSE; FATTY LIVER; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INTRAHEPATIC BILE DUCT; LIVER; LIVER CIRRHOSIS; MICROVASCULATURE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; VASCULARIZATION;

ADOLESCENT; ADULT; ANTIGENS, CD34; ARTERIOLES; BILE DUCTS, INTRAHEPATIC; BIOPSY; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FATTY LIVER; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 81155160162     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182254283     Document Type: Article

References (28)

1. Aleffi S, Petrai I, Bertolani C, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 2005;42:1339-1348. (Pubitemid 43260036)
2. Brock RW, Dorman RB. Obesity, insulin resistance and hepatic perfusion. Microcirculation. 2007;14:339-347. (Pubitemid 47050026)
3. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-2474. (Pubitemid 29420675)
4. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960-967. (Pubitemid 36733754)
5. Clouston AD, Powell EE, Walsh MJ, et al. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology. 2005;41:809-818. (Pubitemid 40462943)
6. Corpechot C, Barbu V, Wendum D, et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 2002;35: 1010-1021. (Pubitemid 34453998)
7. Dunn W, Schwimmer JB. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep. 2008;10:67-72.
8. Elias H, Petty D. Terminal distribution of the hepatic artery. Anat Rec. 1953;116:9-17.
9. Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol. 2003;18:124-138. (Pubitemid 36349857)
10. Ferrell L, Belt P, Bass N. Arterialization of central zones in nonalcoholic steatohepatitis. Hepatology. 2007;46(Supple, Oct):732A; abstract 1113.
11. Ikura Y, Ohsawa M, Naruko T, et al. Expression of the hepatic endothelin system in human cirrhotic livers. J Pathol. 2004;204: 304-310. (Pubitemid 39430090)
12. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321. (Pubitemid 40770284)
13. Kuwahara R, Kofman AV, Landis CS, et al. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology. 2008;47:1994-2002. (Pubitemid 351945566)
14. Lidofsky SD. Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment. Curr Diab Rep. 2008;8:25-30. (Pubitemid 351384872)
15. Medina J, Arroyo AG, Sanchez-Madrid F, et al. Angiogenesis in chronic inflammatory liver disease. Hepatology. 2004;39:1185-1195. (Pubitemid 38569038)
16. Mitra SK. The terminal distribution of the hepatic artery with special reference to arterio-portal anastomosis. J Anat. 1966;100: 651-663.
17. Ohnishi K, Chin N, Sugita S, et al. Quantitative aspects of portalsystemic and arteriovenous shunts within the liver in cirrhosis. Gastroenterology. 1987;93:129-134. (Pubitemid 17084104)
18. Popper H. Pathologic aspects of cirrhosis: a review. Am J Pathol. 1977;87:228-264.
19. Rappaport AM. The microcirculatory acinar concept of normal and pathological hepatic structure. Beitrage zu Pathologie. 1976;157: 215-243.
20. Rappaport AM, MacPhee PJ, Fisher MM, et al. The scarring of the liver acini (Cirrhosis): tridimensional and microcirculatory considerations. Virchows Arch A Pathol Anat Histopathol. 1983;402: 107-137. (Pubitemid 14208538)
21. Rector RS, Thyfault JP, Wei Y, et al. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol. 2008;14:185-192. (Pubitemid 351314297)
22. Richardson MM, Jonsson JR, Powell EE, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology. 2007;133:80-90. (Pubitemid 47031146)
23. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42: 641-649. (Pubitemid 41233657)
24. Theise ND, Kuwahara R. The tissue biology of ductular reactions in human chronic liver disease. Gastroenterology. 2007;133:350-352. (Pubitemid 47031158)
25. Tsutsumi M, Urashima S, Matsuda Y, et al. Changes in type IV collagen content in livers of patients with alcoholic liver disease. Hepatology. 1993;17:820-827. (Pubitemid 23150091)
26. Verrijken A, Francque S, Van Gaal L. The metabolic syndrome and the liver. Acta Gastroenterol Belg. 2008;71:48-59. (Pubitemid 351613489)
27. Weidner N. Chapter 14. Measuring intratumoral microvessel density. Methods Enzymol. 2008;444:305-323.
28. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.